Form D · Pharmaceuticals
Qnovia, Inc.
Richmond, VA · CIK 0001940918
Offering snapshot reported Nov 12, 2024 · SEC filing
- Reported sold
- $14.2M Offering amount: $16M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 29, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 12, 2024 | Initial | $14,210,860 | No comparison | 7 | SEC filing |
| Jun 7, 2023 | Initial | $2,874,968 | No comparison | 3 | SEC filing |
| Aug 8, 2022 | Initial | $24,182,042 | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-529143
Source: Form D, filed Nov 12, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mario Danek | Director, Executive |
| Sean Fahey | Director |
| Brian Quigley | Director, Executive |
| Brian Riano | Director |
| Gregg Smith | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
2920 West Broad St. Suite 243
Richmond, VA, 23230
Richmond, VA, 23230